← Evidence map

ArticlemAbs2025

Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular properties.

Nilufer P Seth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

26 papers cite it

2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39936406